Showing results (181-190 of 341) with videos related to

Sort By:
Pageof 35
European Journal of Heart Failure|November 15, 2023
Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR programJoão Pedro Ferreira, Milton Packer, Javed Butler, et al.
International Journal of Cardiology|March 8, 2017
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational studyShaun G Goodman, Jose C Nicolau, Gema Requena, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trialsJennifer Yu, Roxana Mehran, Tim Clayton, et al.
The American Journal of Cardiology|December 28, 2014
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarctionJosephine Warren, Roxana Mehran, Jennifer Yu, et al.
European Journal of Heart Failure|March 18, 2017
Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trialArnaud Olivier, Bertram Pitt, Nicolas Girerd, et al.
The New England Journal of Medicine|June 11, 2004
A factorial trial of six interventions for the prevention of postoperative nausea and vomitingChristian C Apfel, Kari Korttila, Mona Abdalla, et al.
Journal of the American College of Cardiology|June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical ImprovementsAudinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
European Journal of Heart Failure|July 7, 2022
Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trialStuart J Pocock, João Pedro Ferreira, Milton Packer, et al.
European Journal of Heart Failure|December 1, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trialsJoão Pedro Ferreira, Javed Butler, Stefan D Anker, et al.
JACC. Heart Failure|June 23, 2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, et al.
Pageof 35